Sebastian J Sasu, MD
Pathology · South San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 5
Offices
5 locations · Peninsula Pathologists Medical Group Inc · 17 clinicians in this group
Looking this up.
Hospitals listed: Eden Medical Center · El Camino Health · Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sasu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
California Medical Board record
Licence A89268 · Current
Licensed to practise in California · since 2004 · expires 2028-07-31 · Institute of Medicine and Pharmacy in Cluj-Napoca.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$181,078
Medicare paid this office $181,078 for 1,054 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 407 | $85,273 | $69 |
| Pathology examination of tissue using a microscope, intermediate complexity | 382 | $20,490 | $32 |
| Special stained specimen slides to examine tissue, each additional procedure | 133 | $17,701 | $25 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 52 | $7,970 | $37 |
| Special stained specimen slides to examine tissue, initial procedure | 167 | $7,223 | $31 |
See all 27 services
| Pathology examination of tissue using a microscope, intermediate complexity | 407 | $85,273 | $69 |
| Pathology examination of tissue using a microscope, intermediate complexity | 382 | $20,490 | $32 |
| Special stained specimen slides to examine tissue, each additional procedure | 133 | $17,701 | $25 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 52 | $7,970 | $37 |
| Special stained specimen slides to examine tissue, initial procedure | 167 | $7,223 | $31 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 71 | $5,819 | $73 |
| Pathology examination of tissue using a microscope, moderately high complexity | 51 | $5,011 | $72 |
| Microscopic genetic analysis of tumor, manual | 40 | $3,125 | $37 |
| Evaluation of fine needle aspirate with interpretation and report | 37 | $2,862 | $61 |
| Bone marrow, smear interpretation | 56 | $2,562 | $42 |
| Special stained specimen slides to examine tissue including interpretation and report | 67 | $2,365 | $11 |
| Special stained specimen slides to examine tissue, initial procedure | 50 | $2,006 | $30 |
| Genetic sequencing localization, initial procedure | 37 | $1,895 | $38 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 11 | $1,730 | $157 |
| Preparation of tissue for examination by removing any calcium present | 127 | $1,444 | $10 |
| Special stained specimen slides to examine tissue, each additional procedure | 19 | $1,443 | $24 |
| Evaluation of fine needle aspirate | 35 | $1,356 | $31 |
| Cell examination of specimen, selective cellular enhancement technique | 49 | $1,277 | $24 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 34 | $1,125 | $29 |
| Genetic sequencing localization, each additional procedure | 25 | $986 | $30 |
| Cell examination of specimen, selective cellular enhancement technique | 35 | $807 | $23 |
| Pathology examination of tissue using a microscope, moderately low complexity | 73 | $734 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 15 | $567 | $24 |
| Pap test | 25 | $531 | $20 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $518 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 14 | $140 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 26 | $119 | $4 |
Who their Medicare patients are
1,054 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 11% · Women 58% · Also on Medicaid 24% · Health risk score 1.39. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 67% · Diabetes 27% · Chronic kidney disease 26% · Cancer 26% · Coronary heart disease 22% · Depression 22% · Atrial fibrillation 18% · Heart failure 16% · COPD 14% · Stroke 9% · Dementia 7%.
The office billed $676,811, Medicare allowed $229,436 and paid $181,078; for 4,434 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,054 | 4,434 | 74 | 1.39 | $676,811 | $181,078 |
| 2023 | 1,006 | 4,035 | 74 | 1.18 | $692,048 | $184,475 |
| 2022 | 1,104 | 4,526 | 74 | 1.15 | $818,597 | $217,214 |
| 2021 | 726 | 3,233 | 73 | 1.28 | $560,618 | $152,395 |
| 2020 | 634 | 2,947 | 73 | 1.54 | $481,687 | $129,789 |
| 2019 | 715 | 3,213 | 73 | 1.31 | $542,884 | $143,120 |
| 2018 | 822 | 3,291 | 72 | 1.21 | $610,784 | $157,241 |
| 2017 | 695 | 2,790 | 72 | 1.44 | $458,741 | $120,183 |
| 2016 | 628 | 2,773 | 72 | 1.51 | $353,134 | $94,490 |
| 2015 | 672 | 2,888 | 72 | 1.63 | $332,856 | $87,676 |
| 2014 | 755 | 2,501 | 72 | 1.46 | $276,231 | $70,122 |
| 2013 | 928 | 4,271 | 75 | 1.36 | $907,763 | $161,401 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Pathology examination of tissue using a microscope, intermediate complexity | 568 | $114,884 | $68 |
| Special stained specimen slides to examine tissue, each additional procedure | 101 | $13,162 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 218 | $10,993 | $32 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 56 | $10,076 | $37 |
| Special stained specimen slides to examine tissue, initial procedure | 121 | $4,957 | $31 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 58 | $4,643 | $73 |
| Pathology examination of tissue using a microscope, moderately high complexity | 28 | $2,919 | $73 |
| Special stained specimen slides to examine tissue, initial procedure | 57 | $2,331 | $31 |
| Bone marrow, smear interpretation | 45 | $2,303 | $42 |
| Special stained specimen slides to examine tissue including interpretation and report | 57 | $1,959 | $11 |
| Evaluation of fine needle aspirate with interpretation and report | 18 | $1,260 | $55 |
| Microscopic genetic analysis of tumor, manual | 15 | $1,253 | $37 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 34 | $1,223 | $29 |
| Genetic sequencing localization, initial procedure | 28 | $1,218 | $38 |
| Preparation of tissue for examination by removing any calcium present | 89 | $1,068 | $11 |
| Special stained specimen slides to examine tissue, each additional procedure | 19 | $1,009 | $25 |
| Cell examination of specimen, selective cellular enhancement technique | 37 | $948 | $23 |
| Genetic sequencing localization, each additional procedure | 23 | $902 | $30 |
| Cell examination of specimen, selective cellular enhancement technique | 35 | $875 | $24 |
| Pap test | 37 | $780 | $20 |
| Evaluation of fine needle aspirate | 16 | $540 | $26 |
| Cell examination of body fluid, smears | 19 | $431 | $22 |
| Pathology examination of tissue using a microscope, moderately low complexity | 24 | $259 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 16 | $160 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 22 | $84 | $4 |
2022: 23 services
| Pathology examination of tissue using a microscope, intermediate complexity | 720 | $145,291 | $67 |
| Special stained specimen slides to examine tissue, each additional procedure | 91 | $14,349 | $25 |
| Pathology examination of tissue using a microscope, intermediate complexity | 205 | $13,209 | $33 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 41 | $6,998 | $39 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 73 | $6,110 | $74 |
| Special stained specimen slides to examine tissue, initial procedure | 107 | $4,955 | $31 |
| Bone marrow, smear interpretation | 62 | $3,024 | $42 |
| Pathology examination of tissue using a microscope, moderately high complexity | 26 | $2,976 | $74 |
| Special stained specimen slides to examine tissue, initial procedure | 64 | $2,672 | $33 |
| Special stained specimen slides to examine tissue including interpretation and report | 66 | $2,198 | $11 |
| Genetic sequencing localization, initial procedure | 36 | $1,603 | $39 |
| Genetic sequencing localization, each additional procedure | 32 | $1,140 | $31 |
| Special stained specimen slides to examine tissue, each additional procedure | 13 | $1,084 | $25 |
| Preparation of tissue for examination by removing any calcium present | 84 | $1,015 | $11 |
| Cell examination of body fluid, smears | 39 | $958 | $25 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 23 | $807 | $30 |
| Cell examination of specimen, selective cellular enhancement technique | 27 | $748 | $25 |
| Pathology cytologic examination of specimen during surgery, initial site | 12 | $722 | $56 |
| Pap test | 25 | $494 | $20 |
| Cell examination of specimen, selective cellular enhancement technique | 18 | $451 | $25 |
| Pathology examination of tissue using a microscope, moderately low complexity | 19 | $194 | $10 |
| Pathology examination of tissue using a microscope, moderately low complexity | 14 | $143 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 36 | $141 | $4 |
2021: 22 services
| Pathology examination of tissue using a microscope, intermediate complexity | 424 | $87,349 | $68 |
| Pathology examination of tissue using a microscope, intermediate complexity | 198 | $13,576 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 88 | $10,024 | $26 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 41 | $6,474 | $40 |
| Pathology examination of tissue using a microscope, moderately high complexity | 32 | $5,891 | $77 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 61 | $5,117 | $76 |
| Special stained specimen slides to examine tissue, initial procedure | 104 | $4,975 | $32 |
| Bone marrow, smear interpretation | 60 | $2,847 | $44 |
| Genetic sequencing localization, initial procedure | 32 | $1,602 | $40 |
| Special stained specimen slides to examine tissue including interpretation and report | 69 | $1,570 | $11 |
| Special stained specimen slides to examine tissue, initial procedure | 34 | $1,421 | $32 |
| Genetic sequencing localization, each additional procedure | 28 | $1,181 | $32 |
| Preparation of tissue for examination by removing any calcium present | 84 | $1,028 | $11 |
| Blood smear interpretation by physician with written report | 41 | $932 | $22 |
| Microscopic genetic analysis of tumor, manual | 15 | $928 | $39 |
| Cell examination of specimen, selective cellular enhancement technique | 23 | $714 | $26 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 23 | $704 | $31 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $441 | $25 |
| Pap test | 12 | $256 | $21 |
| Examination of archival tissue for genetic analysis | 13 | $235 | $18 |
| Pathology examination of tissue using a microscope, moderately low complexity | 21 | $219 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 12 | $48 | $4 |
2020: 20 services
| Pathology examination of tissue using a microscope, intermediate complexity | 312 | $61,129 | $67 |
| Special stained specimen slides to examine tissue, each additional procedure | 90 | $12,696 | $27 |
| Pathology examination of tissue using a microscope, intermediate complexity | 194 | $12,359 | $35 |
| Pathology examination of tissue using a microscope, moderately high complexity | 35 | $7,007 | $79 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 30 | $6,057 | $42 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 61 | $5,780 | $78 |
| Special stained specimen slides to examine tissue, initial procedure | 106 | $5,197 | $34 |
| Bone marrow, smear interpretation | 53 | $2,669 | $45 |
| Microscopic genetic analysis of tumor, manual | 28 | $1,833 | $40 |
| Genetic sequencing localization, initial procedure | 34 | $1,743 | $42 |
| Special stained specimen slides to examine tissue including interpretation and report | 66 | $1,586 | $11 |
| Special stained specimen slides to examine tissue, initial procedure | 30 | $1,478 | $33 |
| Genetic sequencing localization, each additional procedure | 31 | $1,181 | $33 |
| Preparation of tissue for examination by removing any calcium present | 84 | $1,089 | $12 |
| Blood smear interpretation by physician with written report | 42 | $997 | $22 |
| Cell examination of specimen, selective cellular enhancement technique | 23 | $733 | $26 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 18 | $705 | $32 |
| Cell examination of specimen, selective cellular enhancement technique | 19 | $471 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 33 | $364 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 25 | $103 | $4 |
2019: 20 services
| Pathology examination of tissue using a microscope, intermediate complexity | 407 | $73,306 | $64 |
| Pathology examination of tissue using a microscope, intermediate complexity | 199 | $13,096 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 96 | $10,832 | $27 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 38 | $7,281 | $40 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 74 | $5,752 | $76 |
| Special stained specimen slides to examine tissue, initial procedure | 118 | $5,367 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 26 | $5,150 | $78 |
| Bone marrow, smear interpretation | 74 | $3,441 | $44 |
| Special stained specimen slides to examine tissue including interpretation and report | 82 | $1,930 | $11 |
| Genetic sequencing localization, initial procedure | 37 | $1,757 | $41 |
| Microscopic genetic analysis of tumor, manual | 21 | $1,543 | $40 |
| Genetic sequencing localization, each additional procedure | 44 | $1,522 | $32 |
| Preparation of tissue for examination by removing any calcium present | 107 | $1,407 | $12 |
| Special stained specimen slides to examine tissue, initial procedure | 25 | $1,247 | $33 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 21 | $769 | $32 |
| Blood smear interpretation by physician with written report | 25 | $586 | $23 |
| Cell examination of specimen, selective cellular enhancement technique | 17 | $523 | $26 |
| Pathology examination of tissue using a microscope, moderately low complexity | 35 | $433 | $11 |
| Cell examination of specimen, selective cellular enhancement technique | 13 | $322 | $23 |
| Pathology examination of tissue using a microscope, limited examination | 20 | $81 | $4 |
2018: 16 services
| Pathology examination of tissue using a microscope, intermediate complexity | 552 | $105,478 | $63 |
| Pathology examination of tissue using a microscope, intermediate complexity | 183 | $10,963 | $36 |
| Special stained specimen slides to examine tissue, each additional procedure | 88 | $10,090 | $27 |
| Special stained specimen slides to examine tissue, initial procedure | 100 | $4,716 | $33 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 47 | $3,470 | $71 |
| Pathology examination of tissue using a microscope, moderately high complexity | 26 | $3,397 | $79 |
| Bone marrow, smear interpretation | 62 | $3,044 | $45 |
| Special stained specimen slides to examine tissue including interpretation and report | 70 | $1,705 | $11 |
| Genetic sequencing localization, initial procedure | 27 | $1,661 | $42 |
| Special stained specimen slides to examine tissue, initial procedure | 36 | $1,614 | $33 |
| Genetic sequencing localization, each additional procedure | 26 | $1,242 | $33 |
| Preparation of tissue for examination by removing any calcium present | 94 | $1,213 | $12 |
| Microscopic genetic analysis of tumor, manual | 15 | $924 | $38 |
| Cell examination of specimen, selective cellular enhancement technique | 15 | $423 | $26 |
| Pathology examination of tissue using a microscope, moderately low complexity | 30 | $382 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 16 | $69 | $4 |
2017: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 379 | $69,398 | $62 |
| Pathology examination of tissue using a microscope, intermediate complexity | 205 | $12,575 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 92 | $11,513 | $26 |
| Special stained specimen slides to examine tissue, initial procedure | 115 | $5,129 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 31 | $4,686 | $78 |
| Bone marrow, smear interpretation | 68 | $3,365 | $45 |
| Special stained specimen slides to examine tissue including interpretation and report | 75 | $1,811 | $11 |
| Microscopic genetic analysis of tumor, manual | 20 | $1,624 | $51 |
| Preparation of tissue for examination by removing any calcium present | 106 | $1,346 | $12 |
| Pathology examination of specimen during surgery, first tissue block | 13 | $939 | $59 |
| Evaluation of fine needle aspirate with interpretation and report | 11 | $921 | $66 |
| Special stained specimen slides to examine tissue, initial procedure | 14 | $625 | $33 |
| Cell examination of specimen, selective cellular enhancement technique | 18 | $514 | $26 |
| Evaluation of fine needle aspirate | 11 | $472 | $34 |
| Pathology examination of tissue using a microscope, moderately low complexity | 41 | $461 | $11 |
| Pap test | 12 | $334 | $28 |
| Pathology examination of tissue using a microscope, limited examination | 20 | $84 | $4 |
2016: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 162 | $26,348 | $64 |
| Pathology examination of tissue using a microscope, intermediate complexity | 326 | $20,035 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 121 | $15,697 | $24 |
| Special stained specimen slides to examine tissue, initial procedure | 137 | $5,861 | $31 |
| Pathology examination of tissue using a microscope, moderately high complexity | 39 | $5,107 | $74 |
| Bone marrow, smear interpretation | 85 | $3,670 | $43 |
| Special stained specimen slides to examine tissue including interpretation and report | 101 | $2,092 | $11 |
| Microscopic genetic analysis of tumor, manual | 27 | $1,640 | $48 |
| Cell examination of specimen, selective cellular enhancement technique | 50 | $1,636 | $25 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 17 | $1,635 | $96 |
| Preparation of tissue for examination by removing any calcium present | 132 | $1,606 | $11 |
| Pathology examination of specimen during surgery, first tissue block | 13 | $1,069 | $56 |
| Special stained specimen slides to identify organisms including interpretation and report | 29 | $944 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 44 | $481 | $10 |
| Cell examination of specimen, selective cellular enhancement technique | 18 | $446 | $25 |
| Pap test | 13 | $333 | $26 |
| Pathology examination of tissue using a microscope | 16 | $133 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 24 | $104 | $4 |
2015: 22 services
| Pathology examination of tissue using a microscope, intermediate complexity | 359 | $22,013 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 133 | $11,899 | $19 |
| Pathology examination of tissue using a microscope, moderately high complexity | 80 | $9,987 | $76 |
| Pathology examination of tissue using a microscope, intermediate complexity | 119 | $7,536 | $34 |
| Special stained specimen slides to examine tissue, initial procedure | 147 | $6,303 | $32 |
| Microscopic genetic analysis of tumor, manual | 44 | $3,929 | $49 |
| Bone marrow, smear interpretation | 84 | $3,922 | $43 |
| Special stained specimen slides to examine tissue including interpretation and report | 103 | $2,126 | $11 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 18 | $1,853 | $98 |
| Preparation of tissue for examination by removing any calcium present | 151 | $1,811 | $11 |
| Cell examination of specimen, selective cellular enhancement technique | 60 | $1,674 | $25 |
| Pathology examination of tissue using a microscope, high complexity | 12 | $1,599 | $133 |
| Special stained specimen slides to identify organisms including interpretation and report | 48 | $1,462 | $24 |
| Evaluation of fine needle aspirate with interpretation and report | 18 | $1,397 | $64 |
| Pathology examination of specimen during surgery, first tissue block | 12 | $1,135 | $57 |
| Pathology examination of tissue using a microscope, moderately low complexity | 68 | $735 | $10 |
| Evaluation of fine needle aspirate | 17 | $687 | $33 |
| Special stained specimen slides to identify organisms including interpretation and report | 19 | $462 | $24 |
| Cell examination of specimen, selective cellular enhancement technique | 15 | $375 | $25 |
| Blood smear interpretation by physician with written report | 15 | $328 | $22 |
| Pathology examination of tissue using a microscope, limited examination | 32 | $145 | $4 |
| Pathology examination of tissue using a microscope | 17 | $110 | $6 |
2014: 20 services
| Pathology examination of tissue using a microscope, intermediate complexity | 304 | $16,724 | $33 |
| Pathology examination of tissue using a microscope, intermediate complexity | 259 | $15,765 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 56 | $6,303 | $73 |
| Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | 90 | $5,244 | $11 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 96 | $3,299 | $27 |
| Microscopic genetic analysis of tumor, manual | 38 | $3,120 | $47 |
| Bone marrow, smear interpretation | 40 | $1,725 | $42 |
| Cell examination of specimen, selective cellular enhancement technique | 54 | $1,499 | $25 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 14 | $1,321 | $94 |
| Pathology examination of specimen during surgery, first tissue block | 14 | $1,210 | $55 |
| Special stained specimen slides to identify organisms including interpretation and report | 38 | $1,148 | $23 |
| Evaluation of fine needle aspirate with interpretation and report | 16 | $1,123 | $62 |
| Preparation of tissue for examination by removing any calcium present | 90 | $1,049 | $11 |
| Special stained specimen slides to examine tissue including interpretation and report | 51 | $993 | $10 |
| Special stained specimen slides to identify organisms including interpretation and report | 37 | $983 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 75 | $809 | $10 |
| Evaluation of fine needle aspirate | 14 | $569 | $32 |
| Cell examination of specimen, selective cellular enhancement technique | 15 | $377 | $24 |
| Pathology examination of tissue using a microscope | 11 | $80 | $6 |
| Pathology examination of tissue using a microscope, limited examination | 15 | $63 | $4 |
2013: 30 services
| Pathology examination of tissue using a microscope, intermediate complexity | 256 | $30,876 | $39 |
| Special stained specimen slides to examine tissue, initial procedure | 110 | $29,183 | $35 |
| Pathology examination of tissue using a microscope, intermediate complexity | 304 | $17,618 | $31 |
| Special stained specimen slides to examine tissue, initial procedure | 31 | $15,660 | $95 |
| Pathology examination of tissue using a microscope, moderately high complexity | 66 | $8,618 | $69 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | 18 | $4,889 | $50 |
| Microscopic genetic analysis of tumor, manual | 47 | $4,793 | $44 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 54 | $4,742 | $88 |
| Special stained specimen slides to identify organisms including interpretation and report | 106 | $4,604 | $39 |
| Pathology examination of specimen during surgery, first tissue block | 36 | $3,114 | $52 |
| Special stained specimen slides to examine tissue including interpretation and report | 89 | $2,734 | $27 |
| Microscopic genetic analysis of tumor, manual | 13 | $2,694 | $112 |
| Special stained specimen slides to examine tissue including interpretation and report | 72 | $2,381 | $10 |
| Pathology examination of tissue using a microscope, high complexity | 17 | $2,323 | $122 |
| Biopsy of bone marrow | 35 | $2,094 | $60 |
| Preparation of tissue for examination by removing any calcium present | 161 | $1,638 | $10 |
| Cell examination of specimen, selective cellular enhancement technique | 32 | $1,605 | $49 |
| Protein measurement, serum | 87 | $1,513 | $17 |
| Bone marrow, smear interpretation | 37 | $1,431 | $39 |
| Cell examination of specimen, selective cellular enhancement technique | 14 | $1,319 | $94 |
| Special stained specimen slides to identify organisms including interpretation and report | 53 | $1,316 | $22 |
| Pathology cytologic examination of specimen during surgery, each additional site | 21 | $1,195 | $32 |
| Pathology examination of tissue using a microscope, moderately low complexity | 101 | $955 | $9 |
| Immunologic analysis technique on serum (immunofixation) | 54 | $881 | $16 |
| Blood smear interpretation by physician with written report | 41 | $805 | $18 |
| New patient visit (10+ min) | 27 | $578 | $21 |
| Pathology examination of tissue using a microscope, moderately low complexity | 12 | $483 | $37 |
| Aspiration of bone marrow sample for diagnosis | 17 | $445 | $26 |
| Crystal identification from tissue or body fluid | 22 | $359 | $16 |
| Pathology examination of tissue using a microscope, limited examination | 40 | $146 | $4 |
Medicaid work
$6,304 in 2024
Medicaid paid $6,304 for 270 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 202 | $4,535 |
| TISSUE EXAM BY PATHOLOGIST | 26 | $1,005 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 42 | $764 |
| 2024 | 270 | 3 | 30 | $6,304 |
| 2023 | 83 | 1 | 19 | $1,120 |
| 2022 | 57 | 1 | 22 | $1,441 |
| 2021 | 75 | 2 | 18 | $2,019 |
| 2020 | 29 | 2 | 15 | $698 |
| 2019 | 51 | 1 | 22 | $428 |
| 2018 | 42 | 1 | 16 | $998 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 83 | $1,120 |
2022
| TISSUE EXAM BY PATHOLOGIST | 57 | $1,441 |
2021
| TISSUE EXAM BY PATHOLOGIST | 59 | $1,529 |
| TISSUE EXAM BY PATHOLOGIST | 16 | $490 |
2020
| TISSUE EXAM BY PATHOLOGIST | 14 | $499 |
| TISSUE EXAM BY PATHOLOGIST | 15 | $199 |
2019
| TISSUE EXAM BY PATHOLOGIST | 51 | $428 |
2018
| TISSUE EXAM BY PATHOLOGIST | 42 | $998 |
Money from drug and device companies
$25 in 2020
A payment is not proof that care is biased.
| Intercept Pharmaceuticals | Ocaliva | $25 | 1 payment
|
See the published payment
| Intercept Pharmaceuticals | Meals · 2020-03-10 | Ocaliva | $25 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 87.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1548387095
- Licence
- CA A89268California A89268: Current · expires 2028-07-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A892680
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X)
- Mailing address
- 1328 22nd St, Santa Monica, CA, 90404
- NPI first listed
- 2007-03-22
- NPI last updated
- 2024-11-05
- NPI record certified
- 2024-11-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1501 Trousdale Dr, Burlingame, CA, 94010 · 815 Pollard Rd, Los Gatos, CA, 95032 · 2500 Grant Rd, Mountain View, CA, 94040 · 170 Alameda De Las Pulgas, Redwood City, CA, 94062